Gilead Sciences to Release First Quarter 2021 Financial Results on Thursday, April 29, 2021 Biotech Investing
Pfizer Invites Shareholders to Attend Virtual-Only 2021 Annual Meeting of Shareholders on April 22 Pharmaceutical Investing
Bellus Health, Inc. Investors: Last Days to Participate Actively in the Class Action Lawsuit Biotech Investing
New Report Reveals That More Than One-Third Of IBS Patients Surveyed State It Has Been More Challenging To Manage Their Symptoms During The COVID-19 Pandemic Medical Device Investing
Merck and Ridgeback Biotherapeutics Provide Update on Progress of Clinical Development Program for Molnupiravir, an Investigational Oral Therapeutic for the Treatment of Mild-to-Moderate COVID-19 Pharmaceutical Investing
Aurinia Pharmaceuticals to Present at the Bloom Burton & Co. Healthcare Investor Conference Biotech Investing
Bristol Myers Squibb Receives European Commission Approval for Opdivo® in Combination with Cabometyx® as First-Line Treatment for Patients with Advanced Renal Cell Carcinoma Biotech Investing
Merck Expands Safer Childbirth Cities Initiative to 20th Community-Led Project Advancing Maternal Health Equity During Black Maternal Health Week Pharmaceutical Investing
Knight to Present at the 2021 Bloom Burton & Co. Healthcare Virtual Investor Conference Medical Device Investing
U.S. FDA Grants Accelerated Approval to Trodelvy® for the Treatment of Metastatic Urothelial Cancer Biotech Investing
